On Avril 24, 2026, NNHPD updated several health product monographs to include critical safety warnings, most notably regarding peripheral neuropathy risks with Vitamin B6 and increased bleeding risks for products containing Citrus Bioflavonoids or Hesperidin when used with blood thinners. While minor revisions were applied to the Acai, Royal Jelly, and Probiotics monographs for consistency and clarity, the update also introduces a comprehensive new Prebiotics monograph. This new regulatory tool replaces the standalone inulin monograph, broadening the compendial scope for the category while implementing revised safety and efficacy requirements.
Updated Monographs:
- Mutlivitamin/Minerals Supplement
- Bioflavonoïdes d'agrumes
- Antioxidants (minor revisions)
- Acai (minor revisions)
- Royal Jelly (minor revisions)
- Probiotics (minor revisions)
